Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. III: anti-CD19 CAR-T cell therapy for patients with non-Hodgkin lymphoma

The treatment and evolution of B-cell non-Hodgkin lymphoma (B-NHL) has undergone important changes in the last years with the emergence of targeted therapies, such as monoclonal antibodies, small molecules, antibody-drug conjugates, and bispecific antibodies. Nevertheless, a significant portion of p...

Descripción completa

Detalles Bibliográficos
Autores principales: Alencar, Alvaro J., Hirayama, Alexandre V., Clé, Diego V., Salvino, Marco Aurélio, Perini, Guilherme, Arrais, Celso, Baiocchi, Otávio, Palma, Leonardo Carvalho, Colturato, Iago, Vaz, Jorge, Chiattone, Ricardo, de Lima, Marcos, Filho, Jayr Schmidt, Nabhan, Samir, Rocha, Vanderson, Guerino-Cunha, Renato L., Chiattone, Carlos S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Hematologia e Hemoterapia 2021
Materias:
Special Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606699/
https://www.ncbi.nlm.nih.gov/pubmed/34794792
http://dx.doi.org/10.1016/j.htct.2021.09.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606699/
https://www.ncbi.nlm.nih.gov/pubmed/34794792
http://dx.doi.org/10.1016/j.htct.2021.09.003

Ejemplares similares